Journals / Türk Anestezi ve Reanimasyon Dergisi / 2003 / Cilt: 31 - Sayı: 7

The postoperative analgesic effects of celecoxib and rofecoxib in total abdominal hysterectomy

Total abdominal histerektomide rofekoksib ve selekoksibin postoperatif analjezik etkinliği

Pages
363–367
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Total morphine consumption was lesser in Group II at 8th h compared to Group III and at 12th and 24th h compared to Group I and III (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Celecoxib and rofecoxib that have been used in our country for treatment of osteoartritis and rheumatoid artritis are two COX-2 selective inhibitor non-steroidal antiinflammatory drugs.
📊
Key Findings & Data:After obtaining approval from Ethics Committee, we studied 60 ASA I-II females undergoing total elective abdominal hysterectomy in a randomised, placebo controlled, double blind study.
💡
Conclusion & Impact:Total morphine consumption was lesser in Group II at 8th h compared to Group III and at 12th and 24th h compared to Group I and III (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Celecoxib and rofecoxib that have been used in our country for treatment of osteoartritis and rheumatoid artritis are two COX-2 selective inhibitor non-steroidal antiinflammatory drugs. The aim of this study is to investigate postoperative analgesic and morphine spa-ring effects of single dose celecoxib or rofecoxib which were given before surgery in patients undergoing total abdominal hysterectomy. After obtaining approval from Ethics Committee, we studied 60 ASA I-II females undergoing total elective abdominal hysterectomy in a randomised, placebo controlled, double blind study. Patients were divided into 200 mg celecoxib (Group I, n=20), 50 mg rofecoxib (Group II, n=20) and placebo (Group III, n=20) groups. Anaesthesia was induced with 1.5 µg kg-1 fentanyl, 4-6 mg kg-1 thiopental and 0.1 mg kg-1 vecuronyum. Morphine consumption, VAS scores at rest, on movement and on coughing and degree of sedation were evaluated during postoperative 2nd, 4th, 8th, 12th, and 24th h. Total morphine consumption was lesser in Group II at 8th h compared to Group III and at 12th and 24th h compared to Group I and III (p

Özet

Ülkemizde osteoartrit ve romatoid artrit tedavisinde kullanılan selekoksib ve rofekoksib COX-2 spesifik inhibitörü iki non-steroid antienflamatuar ilaçtır. Çalışmamızın amacı, total abdominal histerektomi planlanan olgularda, ameliyat öncesi verilen tek doz selekoksib ve rofekoksibin postoperatif analjezik etkinliğini ve morfin tüketimine etkisini araştırmaktır. Etik Kurul onayı alındıktan sonra, total abdominal histerektomi uygulanacak ASA I-II grubu toplam 60 olgu, rasgele, çift kör ve plasebo kontrollü çalışmaya alındı. Olgular 200 mg selekoksib (Grup I, n=20), 50 mg rofekoksib (Grup II, n=20) ve plasebo (Grup III, n=20) gruplarına ayrıldı. Anestezi indüksiyonu; 1.5 µg kg-1 fentanil, 4-6 mg kg-1 tiyopentan ve 0.1 mg kg--1 vekuronyum ile sağlandı. Postoperatif ikinci, 4., 8., 12. ve 24. saatlerde olguların morfin tüketimi; dinlenme, hareket ve öksürük sırasındaki VAS skorları ve sedasyon düzeyleri değerlendirildi. Toplam morfin tüketimi postoperatif 8. saatte Grup II'de Grup III'e göre, 12. ve 24. saatlerde Grup I ve III'e göre anlamlı olarak düşük saptandı (p

🔖

Cite This Article

DEMİRBİLEK, S., KÖROĞLU, A., ÖZGÜL, Ü., ERSOY, M. Ö., DURMUŞ, M. (2022). The postoperative analgesic effects of celecoxib and rofecoxib in total abdominal hysterectomy. Türk Anestezi ve Reanimasyon Dergisi, Cilt: 31 - Sayı: 7, 363–367. https://ajindex.com/articles/620235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hawkey CJ: COX-2 inhibitors. Lancet 1999; 353:307-14
  2. Sinatra R: COX-2 inhibitors in the evolution of acute pain management. J Pain Symptom Manage 2002; 24:18-27
  3. Haas DA: An update on analgesics for the management of acute postoperative dental pain. J Can Dent Assoc 2002; 68:476-82
  4. Simon LS, Weaver AL, Graham DY, et al: Anti-inflammatory and upper gastrointestinal effects of celecoxib İn rheumatoid arthritis. JAMA 1999; 282:1921-8
  5. Souter AJ, Fredman B, While PF: Controversies İn the peri-operative use of non-steroidal antiinflammatory drugs. Anesth Analg 1994; 79:1178-90
  6. Dahl.JB, Kehlet H: Non-steroidal antiinflammatory drugs: rationale for use in severe postoperative pain. Br J Anaesth 1991; 66:703-12
  7. Ehrich EW, Dallob A, De Lepeleire I, et al: Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 1999; 65:336-47
  8. Clemett D, Goa Kl: Celecoxib: a review of its use in osteoar-tritis, rheumatoid artritis and acute pain. Drugs 2000; 59:957-80
  9. Wilson E, David A, Mackenzie N: Sedation during spinal anaesthesia: comparison of propofol and midazolam. Br J Anaesth 1990; 64:48-52
  10. Pertunnen K, Kalso E, Salo J: IV diclofenac in post-thoracotomy pain. Br J Anaesth 1992; 68:474-80
  11. Morrison BW, Christensen S, Yuan W, et al: Analgesic effect of the cyclooxygenase-2-spesific inhibitor rofecoxib in postdental surgery pain: a randomised controlled trial. Clin Ther 1999;21:943-53
  12. Scott RM, Jenning PN: Rectal diclofenac analgesia after abdominal hysterectomy. Aust NZ J Obstet Gynaecol 1997; 37:112-4
  13. Hodsman NB, Burns J, Blyth A, et al: The morphine sparing effects of dicklofenac sodium following abdominal surgery. Anaesthesia 1987; 42:1005-8
  14. Thompson JP, Sharpe P, Kiani S, Owen-Smith O: Effect of meloxicam on postoperative pain after abdominal hysterectomy. Br J Anaesth 2000; 84:151-4
  15. Watcha MF, Issioui T, Klein KW, White PF: Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery. Anesth Analg 2003; 96:987-94.